Establishment of an inflammatory bowel disease-derived colonic organoid model to measure mucin RNA isoform expression and mucosal barrier function

Scope of the method

The Method relates to
  • Human health
The Method is situated in
  • Basic Research
  • Translational - Applied Research
Type of method
  • In vitro - Ex vivo
This method makes use of
  • Human derived cells / tissues / organs
Specify the type of cells/tissues/organs
Organoids established from colonic biopsies of IBD patients

Description

Method keywords
  • inflammation
  • epithelial barrier function
  • mucin RNA isoform expression
  • colonic organoids
  • inflammatory bowel disease
  • tight junctions
  • transwell assays
Scientific area keywords
  • gut barrier
  • therapy
  • cell biology
  • single-cell RNA seq
  • mucus barrier
Method description
Human epithelial organoids are first established from colonic biopsies of IBD patients. Differentiation of the organoids (i.e. transition from stem cell to distinct epithelial-type cells) is characterized by monitoring the expression of LGR5, Ki67, MUC1, MUC2 and MUC13. Subsequently, human epithelial organoid cultures (hEpOCs) are challenged with an inflammatory cocktail to reinduce the inflammatory status as described in IBD patients. Thereafter, the organoids are treated with an IBD drug and mucin expression and barrier function assessed.
Lab equipment
  • - Incubator,
  • - Laminar flow hood,
  • - Microscope,
  • - Transwell system,
  • - TEER measurement system,
  • - RT-qPCR,
  • - GridION (Nanopore) sequencer.
Method status
  • Still in development

Pros, cons & Future potential

Advantages

Organoids mimics the mucosal environment and generates a mini 3D gut organ.

Challenges

Establishment and culturing of organoids is very variable and patient dependent.

Modifications

Generation of 2D co-culture organoid model with immune cells will better mimic the inflammatory situation in IBD patients in stead of the challenge with an inflammatory cocktail.

Future & Other applications

This model can be used in other GI pathologies where barrier dysfunction is a key hallmark.

References, associated documents and other information

References

Pleguezuelos-Manzano C, Puschhof J, van den Brink S, Geurts V, Beumer J, Clevers H. Establishment and Culture of Human Intestinal Organoids Derived from Adult Stem Cells. Curr Protoc Immunol [Internet]. 2020 Sep 1;130(1):e106. Available from: https://doi.org/10.1002/cpim.106

Other remarks

Prof. Benedicte De Winter, University of Antwerp, Laboratory of Experimental Medicine and Pediatrics collaborates with Prof Annemieke Smet and is a partner for this method.

Contact person

Annemieke Smet

Organisations

University of Antwerp (UAntwerpen)
Laboratory of Experimental Medicine and Pediatrics (LEMP)
Belgium
Flemish Region

Partners

University of Antwerp (UAntwerpen)